Blog Posts

Lucky88 đưa tin: Pep Guardiola đề cập 'mối lo ngại' của Rodri và Phil Foden

Posted by lucky on September 20, 2024 at 1:57am 0 Comments

HLV Pep Guardiola của Man City đã đề cập đến “mối lo ngại” của Rodri, Phil Foden và Ilkay Gundogan trước trận đại chiến với Arsenal vào cuối tuần này.

Rodri được đá chính trong trận gặp Inter

Rodri được đá chính trong trận gặp Inter



Xem thêm: https://lucky88.com/



Man City đã bị Inter cầm hòa không bàn thắng trên sân nhà Etihad trong trận mở màn Champions League 2024/25. Rodri được đá chính đầu tiên trong mùa giải trong trận đấu… Continue

Company Formation in Dubai with Lifetime Visa-free

Posted by Shuraa BusinessSetup on September 20, 2024 at 1:55am 0 Comments

Looking for Company Formation in Dubai and Life time Investor Visa free. Benefit from services like business registration, license acquisition, and PRO support. Enjoy 100% foreign ownership, zero taxes, and access to global markets. Start your business in Dubai's strategic location with ease and efficiency. Contact Shuraa today for personalized support and competitive pricing.

Boost Your Productivity: 5 Benefits of Utilizing PDF to Excel Data Entry Services

Posted by Maitri Maheshwari on September 20, 2024 at 1:49am 0 Comments



In the era of digital revolution, many businesses are facing challenges around data management. One of the key elements in any organization is data stored in various forms. As the demand for digital information is increasing on a daily basis, there is also an increase in the use of PDFs as a document format to share information across the web. The major benefit of…

Continue

Escort Service in Aerocity: The Greatest Call Girl Agency

Posted by Miss Sona on September 20, 2024 at 1:47am 0 Comments

Here you can find our Escort Service in Aerocity. Do you experience loneliness? Do you feel tense and stressed out? You have to get out of your daily groove. We are all aware of the upsetting and life-meaningless effects that basic needs may have on people. People emphasize their physical needs in addition to their mental and emotional needs in the modern era. Unfortunately, they are unable to communicate their feelings and grow impatient due to their… Continue

The Generic Oncology Drugs Market To Take A Technologically Advanced Somersault

Sales revenue from generic oncology drugs in 2020 was US$ 23 Bn, which is expected to surge to US$ 41.5 Bn by the end of 2031. Analysts at Persistence Market Research have also predicted the market to rise at a healthy CAGR of 6% over the next ten years.

Instances of cancer cases have risen exponentially across the globe. From diagnosis to treatment, all aspects of the disease are being researched extensively by numerous market players. Oncology treatment and drugs have proven to be very expensive for everyone, and this has been affecting overall treatment of cancer globally.

Research is focusing on developing new and cost-effective generic oncology drugs that would be helpful in treatment of types of cancers. A major trend to watch out for over the decade would be the use of nanotechnology in the development of generic oncology drugs. With cancer rates surging, the need for a diverse portfolio of generic drugs is being realized, and major as well as new market players are investing in developing a vast portfolio that caters to most needs of patients suffering from different cancer conditions.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25480

Prime players in the industry are investing in the research & development of new products, which, in turn, is expanding their product portfolios across various cancer types.

  • In September 2021, MSN Labs, a pharmaceutical firm based in India, announced the launch of its new generic drug that will be used in treatment of renal cancer. The drug is called Cabolong, which is a branded generic of Cabozantinib. The drug will be available for treatment in three strength factors of 20mg, 40mg, and 60mg.
  • In February 2021, Glenmark Pharma, a renowned name in the pharmaceutical industry announced the launch of a new generic cancer drug for the treatment of kidney cancer. This drug is the generic version of FDA approved Suntinib and is named SUTIB.

Company Profiles:

  • Novartis AG
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • CELGENE CORPORATION
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Company, Inc
  • Aurobindo Pharma.
  • Hikma Pharmaceuticals PLC
  • Mylan N.V.
  • NATCO Pharma Limited.
  • Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25480

generic-oncology-drugs-market

Key Takeaways from Market Study

  • The global generic oncology drugs market is predicted to expand at a CAGR of 6% through 2031.
  • Generic oncology drugs revenue is anticipated to top US$ 41.5 Bn by the end of the decade.
  • The South Asia market is predicted to rise at the fastest CAGR over the decade.
  • In 2020, global market revenue totaled a net worth of US$ 23 Bn.
  • Increasing incidence of cancer across the globe, growing focus on healthcare, rising healthcare expenditure, and advancements in treatment technologies and drugs are some of the major factors influencing industry growth.

Key players are focusing on diversifying their product portfolios in order to fulfil high demand for generic oncology drugs,” says a Persistence Market Research analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25480

More Valuable Insights on Offer

Persistence Market Research, a research and consulting firm, has published a new market research report on the global generic oncology drugs market that contains industry analysis of 2016–2020 and opportunity assessment for 2021–2031.

The report provides in-depth analysis of the market through different segments, namely, molecule type, by route of administration, by distribution channel, and region. The report also provides supply and demand trends along with an overview of the parent market.

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Views: 4

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service